Synopsis
NexCAR 19, India’s first cell therapy to treat a specific form of blood cancer, is showing encouraging results. Now listed at 40 hospitals across the country, its indigenous maker, ImmunoACT, is driving a medical revolution. Can the battle against the emperor of all maladies be won?
Have you heard of Emily Whitehead or Thejna John? Well, both are cancer patients once ‘written off’ by doctors. Whitehead, a resident of Philadelphia, US, was diagnosed with acute lymphoblastic leukemia (ALL) in May 2010. She was only five years old. The disease had become resistant to treatment, and it was expected to claim her life within a few weeks. John, a 27-year-old from Kerala’s Kollam district, underwent bone marrow transplant after
- FONT SIZE
AbcSmall
AbcMedium
AbcLarge
Uh-oh! This is an exclusive story available for selected readers only.
Worry not. You’re just a step away.
Why ?
Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors
Stock analysis. Market Research. Industry Trends on 4000+ Stocks
Clean experience with
Minimal Ads
Comment & Engage with ET Prime community 
Exclusive invites to Virtual Events with Industry Leaders 
A trusted team of Journalists & Analysts who can best filter signal from noise 
Get 1 Year Complimentary Subscription of TOI+ worth Rs.799/-
